A 10-year follow-up study of contraceptive Norplant implants
- PMID: 10699196
- DOI: 10.1016/s0020-7292(99)00214-3
A 10-year follow-up study of contraceptive Norplant implants
Abstract
Objectives: To evaluate the long-term efficacy and health problems associated with Norplant implants and re-implants after 5 full years of first implants.
Method: From 1984 to 1988, 1657 women accepted first implants of Type I and Type II of Norplant, and 394 first acceptors had a re-implant, at a clinic for study. The clinical records and annual follow-up data of acceptors were analyzed. The life-table technique was the main method used.
Results: The continuation rates were very high. The cumulative pregnancy rates at 1, 3 and 5 full years of use were 0.0%, 0.1% and 0.7%, respectively. Users with heavier body weight had higher pregnancy rates. The rate of menstrual disturbances peaked at 73% after 3 months and consistently decreased to 20% at 5 years of use. Rates of menstrual disturbances associated with re-implants were much lower.
Conclusion: Norplant is extremely effective and safe for long-term use.
Similar articles
-
The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.Hum Reprod. 1998 Dec;13(12):3371-8. doi: 10.1093/humrep/13.12.3371. Hum Reprod. 1998. PMID: 9886517 Clinical Trial.
-
A 5-year clinical evaluation of Norplant implants in Senegal.Contraception. 1999 Jun;59(6):377-81. doi: 10.1016/s0010-7824(99)00046-3. Contraception. 1999. PMID: 10518232 Clinical Trial.
-
A cohort study of Norplant implant: side-effects and acceptance.Adv Contracept. 1995 Jun;11(2):97-114. doi: 10.1007/BF01987275. Adv Contracept. 1995. PMID: 7491860
-
Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.
-
Hormonal implants: contraception for a new century.Am J Obstet Gynecol. 1994 May;170(5 Pt 2):1536-43. doi: 10.1016/s0002-9378(94)05016-7. Am J Obstet Gynecol. 1994. PMID: 8178903 Review.
Cited by
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article.
-
The association between body weight, unintended pregnancy resulting in a livebirth, and contraception at the time of conception.Matern Child Health J. 2005 Dec;9(4):413-20. doi: 10.1007/s10995-005-0015-5. Matern Child Health J. 2005. PMID: 16235025
MeSH terms
Substances
LinkOut - more resources
Full Text Sources